ArticleRadiation oncology (London, England)2019

Treatment-duration is related to changes in peripheral lymphocyte counts during definitive radiotherapy for unresectable stage III NSCLC.

Qianqian Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.